Cancer-related fatigue: Prevalence, assessment and treatment strategies

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 11, Issue 4, 2011, Pages 441-446

  Weis, Joachim ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

anxiety; assessment; cancer related fatigue; counseling; depression; physical exercise; prevalence rate; psychosocial interventions

Indexed keywords

ALPHA INTERFERON; AMFEBUTAMONE; CARNITINE; CORTICOSTEROID; CYTOKINE; METHYLPHENIDATE; MODAFINIL; PAROXETINE; PSYCHOSTIMULANT AGENT;

BLOOD PRESSURE; CANCER FATIGUE; CANCER PAIN; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EXERCISE; HUMAN; LABORATORY TEST; MEDICAL HISTORY; MEDICAL INFORMATION; PATIENT COUNSELING; PHYSICAL EXAMINATION; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SPORT; STRATEGIC PLANNING; TREATMENT PLANNING; VERTIGO; WESTERN HEMISPHERE; XEROSTOMIA;

ACTIVITIES OF DAILY LIVING; ANEMIA; ANTINEOPLASTIC AGENTS; FATIGUE; HUMANS; NEOPLASMS; PREVALENCE; QUALITY OF LIFE;

EID: 80051770242     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.11.44     Document Type: Review

References (68)

1. Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br. J. Cancer 91, 822-828 (2004). (Pubitemid 39273769)
2. Henry DH, Viswanathan HN, Elkin EP et al. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional survey in the US. Support Care Cancer 16, 791-801 (2008).
3. Cella D, Davis K, Breitbart W, Curt G. Cancer related fatigue: prevalence of porposed diagnostic criteria in a United States sample of cancer survivors. J. Clin. Oncol. 19, 3385-3391 (2001). (Pubitemid 32642191)
4. Servaes P, van-der-Werf S, Prins J, Verhagen S, Bleijenberg G. Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer 9, 11-17 (2001). (Pubitemid 32125584)
5. Irvine D, Vincent L, Graydon J. Bubela N, Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. Cancer Nurs. 17(5), 367-378 (1994).
6. Morrow GR, Andrews PL, Hickok JT et al. Fatigue associated with cancer and its treatment. Support Care Cancer 10, 389-398 (2002).
7. Stone P, Richardson A, Ream E, Smith A, Kerr D, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-center patient survey. Cancer Fatigue Forum. Ann. Oncol. 11(8), 971-975 (2000).
8. Ruffer JU, Flechtner H, Tralls P et al. Fatigue in long-term survivors of Hodgkin's lymphoma: a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur. J. Cancer 39, 2179-2186 (2003). (Pubitemid 37297743)
9. Berglund G, Boland C, Fornandes T et al. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur. J. Cancer 27, 1075-1081 (1991).
10. Bower J, Ganz P, Demsond K, Rowland J, Meyerowitz B, Belin R. Fatigue in breast cancer survivors: occurrence, correlates, an impact of quality of life. J. Clin. Oncol. 18, 743-753 (2000). (Pubitemid 30106604)
11. Olson K, Krawchuk A, Quddusi T. Fatigue in individuals with advanced cancer in active treatment and palliative settings. Cancer Nurs. 30, E1-10 (2007).
12. Curt G, Breitbart W, Cella D et al. Impact of cancer related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5, 353-360 (2000).
13. Passik SD, Kirsh KL, Donaghy K et al Patient related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaires. J. Pain Symptom Manage. 24, 481-449 (2002).
14. Stone P, Richardson A, Ream E et al. Cancer-related fatigue: inevitable, unimportant, and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann. Oncol. 11, 971-975 (2000).
15. Servaes P, Verhagen S, Schreuder HW et al. Fatigue after treatment for malignant and benign bone and soft tissue tumors. J. Pain Symptom Manage. 26, 1113-1122 (2003). (Pubitemid 37488019)
16. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur. J. Cancer 38, 27-43 (2002). (Pubitemid 34031823)
17. Neitzert C, Ritvo P, Dancey J, Weiser K, Murray C, Avery J. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant. 22, 409-422 (1998). (Pubitemid 28412470)
18. Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav. Immun. 21, 863-871 (2007). (Pubitemid 47285683)
19. Schubert C, Hong S, Natarajan L et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun. 21, 413-427 (2007). (Pubitemid 46528677)
20. Strasser F, Palmer JL, Schover LR et al. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer 107, 2949-2957 (2006). (Pubitemid 44937051)
21. Berger AM, Wielgus K, Hertzog M et al. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 18, 105-114 (2010).
22. Rich TA. Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J. Support Oncol. 5, 167-174 (2007). (Pubitemid 46929228)
23. Morrow GR, Hickok JT, Andrews PL et al. Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea? Psychophysiology 39, 491-495 (2002).
24. Miller AH, Ancoli-Israel S, Bower JE et al. Neuroendocrine immune mechanisms of behavioral comorbidities in patients with cancer. J. Clin. Oncol. 26, 971-982 (2008). (Pubitemid 351409339)
25. Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur. J. Cancer Care 10, 245-255 (2001). (Pubitemid 33699428)
26. Hinds PD, Hockenberry M, Rai SN et al. Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol. Nurs. Forum 34, 393-402 (2007).
27. Loge J, Abrahamsen A, Ekeberg O, Kaasa S. Fatigue and psychiatric morbidity among Hodgkin's disease survivor. J. Pain Symptom Manage. 19(2), 91-99 (2000). (Pubitemid 30116798)
28. Patrick DL, Ferketich SL, Frame PS et al. National Institutes of Health state-of-the-science conference statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J. Natl Cancer Inst. 95, 1110-1117 (2003).
29. Valentine A, Meyers C. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer 96(Suppl. 6), 1694-1698 (2001). (Pubitemid 32939177)
30. Visser M, Smets E. Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer, 6, 101-108 (1998). (Pubitemid 28110532)
31. Hayes J. Depression and chronic fatigue in cancer patients. Prim. Care 18(2), 327-339 (1991).
32. Gaston-Johansson F, Fall-Dickson J, Bakos A, Kennedy M. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Practice 7(5), 240-247 (1999). (Pubitemid 29441160)
33. Glaus A. Fatigue in Patients with Cancer: Analysis and Assessment. Heidelberg: Springer, Berlin, Germany (1998).
34. Wettergren L, Langius A, Björkholm M, Björvell H. Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation - a prospective study. Bone Marrow Transplant. 20, 497-502 (1997). (Pubitemid 27434899)
35. Ashbury F, Findlay H, Reynolds B, McKerracher K. A canadian survey of cancer patients' experiences: are their needs being met? J. Pain Symptom Manage. 16(5), 298-306 (1998). (Pubitemid 28545910)
36. Spelten ER, Verbeek JAHM, Uitterhoeve ALJ et al. Cancer, fatigue and the return of patients to work - a prospective cohort study. Eur. J. Cancer 39, 1562-1567 (2003). (Pubitemid 36829196)
37. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 362, 640-650 (2003). (Pubitemid 37013308)
38. Butt Z, Wagner LI, Beaumont JL. Use of a single item screening instrument to detect clinically relevant fatigue, distress, pain and anorexia in ambulatory cancer practice. J. Pain Symptom Manage. 35, 20-30 (2008).
39. Cella D. The functional assessment of Cancer Therapy Anemia and Fatigue Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Seminar Hematolog. 34(3), 13-19 (1997). (Pubitemid 27319140)
40. Mendoza TR, Wang XS, Kugaya A et al. The rapid assessment of fatigue severity in cancer patients; use of the brief Fatigue Inventory. Cancer 85(5), 1186-1196 (1999). (Pubitemid 29115600)
41. Smets EMA, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychometric Res. 39(5), 315-325 (1995).
42. Perneger T, Leplege A, Etter J. Cross-cultural adaptation of a psychometric instrument: two methods compared. J. Clin. Epidemiol. 52, 1037-1046 (1999). (Pubitemid 29469806)
43. Morrow GR, Shelke AR, Roscoe JA et al. Management of cancer-related fatigue. Cancer Invest. 23, 229-239 (2005).
44. Hinds PS, Quargneti A, Bush AJ et al. An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer. Eur. J. Oncol. Nurs. 4, 6-19 (2000).
45. Mitchell SA, Beck SL, Hood LE et al. Putting evidence into practise: evidence-based interventions for fatigue during and following cancer and its treatment. Clin. J. Oncol. Nurs. 11, 99-113 (2007).
46. Barsevick AM, Dudley W, Beck S et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 100, 1302-1310 (2004). (Pubitemid 38325960)
47. Mock V, Frangakis C, Davidson NE et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology 14, 464-477 (2005). (Pubitemid 40883418)
48. Schwartz AL. Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract. 8, 16-24 (2000). (Pubitemid 30060903)
49. Schwartz AL, Mori M, Gao R et al. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med. Sci. Sports Exerc. 33, 718-723 (2001). (Pubitemid 32336630)
50. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst. Rev. 16(2), CD006145 (2008).
51. Schmitz KH, Courneya KS, Matthews C et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 42, 1409-1426 (2010).
52. Zick SM, Alrawi S, Merel G et al. Relaxation acupressure reduces persistent cancer-related fatigue. Evid. Based Complement. Alternat. Med. 2011, pii: 142913 (2011).
53. Sood A, Barton DL, Bauer BA, Loprinzi CL. A critical review of complementary therapies for cancer-related fatigue. Integr. Cancer Ther. 6, 8-13 (2007).
54. Kim SD, Kim HS. Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients. J. Clin. Nurs. 14, 51-55 (2005).
55. Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int. J. Behav. Med. 12, 278-285 (2005). (Pubitemid 41566766)
56. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst. Rev. CD006953 (2009).
57. Jacobsen PB, Donovan KA, Vadaparamil ST, Small BJ. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 26, 660-667 (2007). (Pubitemid 350161067)
58. Mar Fan HG, Clemons M, Xu W et al. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Center 16, 577-583 (2008).
59. Moraska AR, Sood A, Dakhil SR et al. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Treatment Group NCCTG-N05C7 trial. J. Clin. Oncol. 28, 3673-3367 (2010).
60. Lasheen W, Walsh, D, Mahmoud F et al. Methylphenidate side effects in advanced cancer: a retrospective analysis. Am. J. Hosp. Palliat. Care 27(1), 16-23 (2010).
61. Lower EE, Fleishman S, Cooper A et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J. Pain Symptom Manage. 38(5), 650-662 (2009).
62. Cooper MR, Bird HM, Steinberg M, Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann. Pharmacother. 43, 721-725 (2009).
63. Jean-Pierre P, Morrow GR, Roscoe JA et al. A Phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 116, 3513-3520 (2010).
64. Cruciani RA, Dvorkin E, Homel P et al. l-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann. NY Acad. Sci. 1033, 168-176 (2004). (Pubitemid 39656749)
65. Barton DL, Soori GS, Bauer BA et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Cancer Care, 18, 179-187 (2010).
66. Minton O, Richardson A, Sharpe M et al. Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst. Rev. 7, CD006704 (2010).
67. Peuckmann-Post V, Elsner F, Krumm N, Trottenberg R, Radbruch L, Pharmacological treatments for fatigue associated with palliative care Cochrane Database Syst. Rev. 10(11), CD006788 (2010
68. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Cancer Related Fatigue. Version 1.2011 (2011) www.nccn.org/ professionals/physician- gls/f-guidelines.asp